Kyowa Kirin
Andrew Hewitson is an accomplished professional in the pharmaceutical industry with extensive experience in training, capability building, and medical science liaison roles. Currently serving as the Head of Training & Capability Building at Kyowa Kirin Co., Ltd. since July 2022, Andrew previously held the position of EMEA MSL Director at Kyowa Kirin International plc. from August 2020 to July 2022. Andrew's career at AstraZeneca spanned from 2002 to July 2020, where roles included Medical Transformation Lead and Head of Learning and Development, focusing on professional development and training for commercial teams during significant product launches. Andrew began in medical sales at Takeda from January 2001 to 2002 and possesses a rich background in learning about and communicating complex medical data as a Medical Science Liaison. Andrew's foundational education was completed at Laxton Grammar School from 1982 to 1989.
This person is not in any teams
This person is not in any offices
Kyowa Kirin
5 followers
Kyowa Hakko Kirin Co., Ltd. is mainly engaged in medical product and Biochemical businesses. The Medical Product segment is engaged in the manufacture, sale and sales promotion of ethical drug and reagent for clinical test, the development of candidate substances for new drugs, as well as the research and development of technologies for antibody drug creation, among others. It also involved in the contracting, retail and wholesale, and insurance agency businesses. The Biochemical segment manufactures and sells medical and industrial materials, mainly amino and nucleic acids, and healthcare products. This segment also designs and constructs facilities.